In cancer patients who undergo surgery, legalizing medical marijuana with state-run dispensaries may lead to fewer prescriptions for strong opioids.

This pre-clinical study demonstrates a broad potential application for pafolacianine in pediatric solid tumor ...

Adjuvant treatment with Alecensa (alectinib) elicited a 4-year overall survival (OS) rate of 98.4% for patients with resected ALK-positive early stage non–small cell lung cancer (NSCLC) according to ...

Montreal researchers have developed a new tool to fight glioblastoma, a brain cancer so ruthless that some call it the ...

Discover Delcath’s innovative liver-targeted chemotherapy system and latest clinical data driving potential market expansion.

Adjuvant treatment with alectinib (Alecensa) yielded a 4-year overall survival (OS) rate of 98.4% in patients with resected, ALK mutation-positive, early stage non–small cell lung cancer (NSCLC), ...

Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular ...

Richard found what she was looking for. On Sept. 30, she became the first lung surgery patient at Northwestern Medicine to ...

By cracking a medical mystery, Northwestern Medicine researchers may be on the cusp of discovering new drugs to treat the ...

A Salisbury mum whose rib pain and dizziness were put down to the demands of working 60-hour weeks was later diagnosed with lung cancer ...

New research from UCLA Health reveals that women continue to face barriers in accessing lung transplants compared to men, ...